HIV clinical trials
354 active trials name this condition (recorded in the registry as “HIV Infection”) . Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
- Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age
- Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
- reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
- Enhancing Smoking Cessation for African American People Everywhere
- A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV
- Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
- Shared Decision Making to Treat Or Prevent (STOP) HIV in Criminal Legal Involved Populations (R33)
- IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study
- Menopausal HT for Women Living With HIV (HoT)
- 1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
- Cefixime Clinical Trial
- Small Trial of Alendronate Impact on the Reservoir of HIV
- Improving HIV Care Continuum Outcomes Among Formerly Incarcerated Individuals Through Critical Time Legal Interventions
- Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children
- Incretin Microdosing for Cardiometabolic Health in People With HIV
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
- Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care
- HIV Treatment Adherence Dose Determination Trial
- Efficacy of mHealth + e-Navigator Stepped Care Intervention for ART Adherence Among Latino Men With HIV
- Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
- PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
- A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- Boosting Olfactory and Sensory Training Study (BOOST)
- Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
- Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
- Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV
- HIV, Equity, and Addiction Training (HEAT) Program
- Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
- Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
- Alcohol Research in HIV: Relapse Prevention
- Baricitinib for Reduction of HIV - CNS
- TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
- Wellness Intervention for Smoking and HIV
- Low Dose Naltrexone for Pain in Patients With HIV
- RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry
- Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders
- The DART DELIVER-02 Study
- Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes
- Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
- An Integrated Intervention Using a Pill Ingestible Sensor System
- CAR-T Cells for HIV Infection
- HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
- Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH
- Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
- Dasatinib for HIV-1 Reservoir Reduction
- Optimizing Tobacco Treatment Delivery for People Living With HIV
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “HIV Infection” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.